abstract |
The invention relates to new emulsion formulations comprising polyethylene glycol (15)- hydroxystearate, polyglyceryl-3 oleate and one, two, three or more anti-cancer drugs as well as such emulsion formulations for use in the treatment of cancer and a method for producing such emulsion formulations.Preferably, the emulsion formulation can further comprise one or more immunomodulatory drugs or adjuvant. |